Pharmaron Beijing Co., Ltd. (FRA:17Q1)
Germany
· Delayed Price · Currency is EUR 2.340
-0.020 (-0.85%)
At close: Dec 5, 2025
Pharmaron Beijing Ratios and Metrics
Market cap in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 5,948 | 5,538 | 6,044 | 10,440 | 14,727 | 11,807 | Upgrade
|
| Market Cap Growth | -10.52% | -8.38% | -42.11% | -29.11% | 24.73% | 135.07% | Upgrade
|
| Enterprise Value | 6,517 | 6,051 | 6,558 | 10,861 | 14,635 | 11,383 | Upgrade
|
| Last Close Price | 2.34 | 1.69 | 1.56 | 3.96 | 5.41 | 5.44 | Upgrade
|
| PE Ratio | 32.85 | 23.33 | 29.59 | 55.98 | 64.05 | 80.43 | Upgrade
|
| PS Ratio | 3.67 | 3.41 | 4.11 | 7.50 | 14.29 | 18.37 | Upgrade
|
| PB Ratio | 3.27 | 2.94 | 3.58 | 7.10 | 10.33 | 10.56 | Upgrade
|
| P/TBV Ratio | 4.61 | 4.16 | 5.27 | 10.90 | 14.50 | 13.21 | Upgrade
|
| P/FCF Ratio | 62.09 | 78.07 | - | - | - | 283.35 | Upgrade
|
| P/OCF Ratio | 15.32 | 16.24 | 17.20 | 35.91 | 51.70 | 57.20 | Upgrade
|
| EV/Sales Ratio | 3.96 | 3.73 | 4.46 | 7.80 | 14.20 | 17.71 | Upgrade
|
| EV/EBITDA Ratio | 17.48 | 17.71 | 21.15 | 35.94 | 57.09 | 68.62 | Upgrade
|
| EV/EBIT Ratio | 27.62 | 26.60 | 30.42 | 48.04 | 73.04 | 89.13 | Upgrade
|
| EV/FCF Ratio | 68.03 | 85.31 | - | - | - | 273.19 | Upgrade
|
| Debt / Equity Ratio | 0.42 | 0.42 | 0.73 | 0.56 | 0.51 | 0.12 | Upgrade
|
| Debt / EBITDA Ratio | 2.08 | 2.17 | 3.71 | 2.59 | 2.72 | 0.75 | Upgrade
|
| Debt / FCF Ratio | 7.98 | 11.15 | - | - | - | 3.16 | Upgrade
|
| Asset Turnover | 0.55 | 0.49 | 0.49 | 0.53 | 0.49 | 0.47 | Upgrade
|
| Inventory Turnover | 6.86 | 7.60 | 7.23 | 7.55 | 9.92 | 14.65 | Upgrade
|
| Quick Ratio | 1.03 | 1.44 | 2.58 | 1.31 | 2.58 | 2.57 | Upgrade
|
| Current Ratio | 1.50 | 1.80 | 2.98 | 1.67 | 2.90 | 2.80 | Upgrade
|
| Return on Equity (ROE) | 9.66% | 12.48% | 13.14% | 12.80% | 16.85% | 13.68% | Upgrade
|
| Return on Assets (ROA) | 4.91% | 4.26% | 4.50% | 5.36% | 5.97% | 5.84% | Upgrade
|
| Return on Capital (ROIC) | 5.85% | 4.98% | 5.29% | 6.40% | 7.08% | 6.76% | Upgrade
|
| Return on Capital Employed (ROCE) | 9.40% | 8.70% | 7.40% | 10.10% | 9.40% | 10.30% | Upgrade
|
| Earnings Yield | 3.04% | 4.29% | 3.38% | 1.79% | 1.56% | 1.24% | Upgrade
|
| FCF Yield | 1.61% | 1.28% | -0.24% | -1.05% | -0.03% | 0.35% | Upgrade
|
| Dividend Yield | 1.00% | 1.57% | 1.64% | 0.69% | 0.51% | 0.31% | Upgrade
|
| Payout Ratio | 34.92% | 30.24% | 27.78% | 29.45% | 17.14% | 11.55% | Upgrade
|
| Buyback Yield / Dilution | 0.45% | 0.11% | 0.05% | 2.40% | -1.97% | -20.06% | Upgrade
|
| Total Shareholder Return | 1.45% | 1.68% | 1.69% | 3.09% | -1.46% | -19.75% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.